Moreover, our study is the first report to demonstrate that activation of NF-κB leads to the feed-forward activation of STAT3, and to test the efficacy of combined inhibition of NF-κB and STAT3 in vivo in GBM. This evidence concerns the gene NFKB1 and glioblastoma.